{"id":"W2012154624","doi":"10.1007/s00403-009-0961-7","title":"Humanized anti-CD2 monoclonal antibody treatment of plaque psoriasis: efficacy and pharmacodynamic results of two randomized, double-blind, placebo-controlled studies of intravenous and subcutaneous siplizumab","year":2009,"lang":"en","type":"article","venue":"Archives of Dermatological Research","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":16,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research; Dalhousie University; University of Windsor; Innovaderm (Canada)","funders":"","keywords":"Psoriasis Area and Severity Index; Medicine; Placebo; Psoriasis; Pharmacodynamics; Gastroenterology; Internal medicine; Randomized controlled trial; Pharmacokinetics; Randomization; Body surface area; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007967103,0.0003533865,0.002695293,0.0005209107,0.0001816817,0.000008239365,0.0002793247,0.0001868739,0.00001973516],"category_scores_gemma":[0.0005685796,0.0002290887,0.0003152828,0.0002109791,0.002452934,0.0000504661,0.0001368325,0.0002151045,0.000002711477],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001903995,"about_ca_system_score_gemma":0.0001097037,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001059433,"about_ca_topic_score_gemma":0.00001542357,"domain_scores_codex":[0.9956834,0.001791283,0.001311658,0.0005031624,0.0001842594,0.0005261928],"domain_scores_gemma":[0.9898266,0.009041721,0.0005309729,0.0003274418,0.0001951932,0.00007813986],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7050182,0.00191235,0.0003668696,0.0001201359,0.002785067,0.0001016054,0.002715938,0.00001642949,0.2633002,0.00205156,0.000007456335,0.02160415],"study_design_scores_gemma":[0.805938,0.003871931,0.001913847,0.0001559525,0.0007175347,0.0003453581,0.0004603232,0.0001217955,0.1838418,0.002420332,0.00001654791,0.0001965402],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9740273,0.02257796,0.00001790058,0.0002221927,0.00005865711,0.002221204,0.0001457365,0.00002087452,0.0007081749],"genre_scores_gemma":[0.9755187,0.02381392,0.0003347488,0.000004240111,0.0000144951,0.00007228197,0.000123023,0.00001184638,0.0001067207],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1009198,"threshold_uncertainty_score":0.9341965,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07611136627480423,"score_gpt":0.3938231686284702,"score_spread":0.3177118023536659,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}